CD44 and neoplasm: Notably, under Y15 treatment, CM from ID1OE M1-like macrophages no longer enhanced tumor cell invasiveness, tumor sphere-forming ability, or CD44 protein abundance (Fig. 4s; Supplementary Fig. 3r, s).